Psilocybin, a psychedelic compound found in certain species of mushrooms, has long been studied for its potential therapeutic benefits. A recent study published in Nature explores the effects of psilocybin on cognitive flexibility, psychological insight, and well-being over the course of one month.

The study found that a single dose of 25 mg psilocybin led to increased cortical signal entropy (EEG) at 1- and 2-hours post-dosing, which in turn predicted improved psychological well-being at one-month. This effect was exclusive to the 25 mg dose of psilocybin, with no effects observed at a lower dose of 1 mg or with a placebo.

The study also revealed that next-day psychological insight mediated the relationship between entropy and well-being. In other words, the increased cognitive flexibility and psychological insight observed immediately after dosing played a key role in the long-term benefits to well-being.

These findings are significant because they suggest that psilocybin may offer lasting benefits for individuals struggling with mental health issues such as depression or anxiety. The study’s results also highlight the potential of psychedelics to enhance cognitive function and promote emotional well-being, particularly when used in conjunction with other therapeutic approaches.